Skip to main content
SpringerLink
Log in

The first component of human complement (C1): Activation and control

  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Allan R, Isliker R (1974) Studies on the complement binding site of rabbit IgG. II. The reaction of rabbit IgG and its fragments with C1q. Immunochemistry 11: 243

    Google Scholar 

  2. Arlaud GJ, Villiers CL, Chesne S, Colomb M (1980) Purified proenzyme C1r. Some characteristics of its activation and subsequent proteolytic cleavage. Biochim Biophys Acta 616: 116

    Google Scholar 

  3. Arlaud GJ, Gagnon J, Porter RR (1982) The catalytic chain of human complement subcomponent C\(C\overline {1r}\). Biochem J 201: 49

    Google Scholar 

  4. Augener W, Grey HM, Cooper NR, Muller-Eberhard HJ (1971) The reaction of monomeric and aggregated immunoglobulins with C1. Immunochemistry 8: 1011

    Google Scholar 

  5. Barkas T, Scott GK, Fothergill JE (1973) Purification, characterization and active site-studies on human serum complement subcomponent C1s. Biochem Soc Trans 1: 1219

    Google Scholar 

  6. Bartholemew RM, Esser AF (1980) Mechanism of antibody-independent activation of the first component of complement (C1) on retrovirus membranes. Biochemistry 19: 2847

    Google Scholar 

  7. Bauer J, Valet G (1981) Conformational changes of the subunits C1q, C1r and C1s of human complement component C1 demonstrated by 125I-labelling. Biochim Biophys Acta 670: 129

    Google Scholar 

  8. Betz SJ, Isliker H (1981) Antibody independent interaction between Escherichia coli J5 and human complement components. J Immunol 127: 1748

    Google Scholar 

  9. Bing, DH, Almeda S, Isliker H, Lahav J, Hynes RO (1982) Fibronectin binds to the C1q component of complement. Proc Natl Acad Sci USA 79:4198

    Google Scholar 

  10. Boackle RJ, Johnson BJ, Caughman GB (1979) An IgG primary sequence exposure theory for complement activation using synthetic peptides. Nature 282: 742

    Google Scholar 

  11. Boyle MDP, Young M (1982) Nerve growth factor: Activation of the classical complement pathway by specific substitution for component C\(1\). Proc Natl Acad Sci USA 79: 2519

    Google Scholar 

  12. Burton DR, Boyd J, Brampton AD, Easterbrook-Smith SB, Emanuel EJ, Novotony J, Rademacher TW, van Schravendijk MR, Sternberg MJE, Dwek RA (1980) The C1q receptor site on immunoglobulin G. Nature 288: 338

    Google Scholar 

  13. Calcott MA, Müller-Eberhard HJ (1972) C1q protein of human complement. Biochemistry 11:3443

    Google Scholar 

  14. Chesne S, Villiers CL, Arlaud GJ, Lacroix MB, Colomb MG (1982) Fluid phase interaction of C1 inhibitor (C1-Inh) and the subcomponents \(C\overline {1r}\) and \(C\overline {1s}\) of the first component of complement, C1. Biochem J 201: 61

    Google Scholar 

  15. Claus DR, Siegel J, Petras K, Osmand AP, Gewurz H (1977) Interactions of C-reactive protein with the first component of human complement. J Immunol 119: 187

    Google Scholar 

  16. Colomb M, Porter RR (1975) Characterization of a plasmin-digest fragment of rabbit immunoglobulin gamma that binds antigen and complement. Biochem J 145: 177

    Google Scholar 

  17. Cooper NR, Ziccardi RJ (1976) The nature and reactions of complement enzymes. In: Ribbons DW, Brew K (eds) Proteolysis and physiological regulation, Vol. 11. Miami Winter Symposium, Academic Press, New York, P 167

    Google Scholar 

  18. Cooper NR (1983) Activation and regulation of the first complement component. Fed Proc 42: 134

    Google Scholar 

  19. Cooper NR, Morrison DC (1978) Binding and activation of the first component of human complement by the lipid A region of lipopolysaccharides J Immunol 120: 1862

    Google Scholar 

  20. Cooper NR, Jensen FC, Welsh Jr RM, Oldstone MBA (1976) Lysis of RNA tumor viruses by human serum: direct antibody independent triggering of the classical complement pathway. J Exp Med 144: 970

    Google Scholar 

  21. Cooper NR, Miles LA, Griffin JH (1983) Cleavage and activation of the first complement component by plasmin (to be published)

  22. Curd JG, Prograis LJ Jr, Cochrane CG (1980) Detection of active kallikrein in induced blister fluids of hereditary angioedema patients. J Exp Med 152: 742

    Google Scholar 

  23. Curd JG, Yelvington M, Ziccardi RJ, Mathison DA, Griffin JH (1981) Purification and characterization of two functionally distinct forms of C1 inhibitor from a patient with angioedema. Clin Exp Immunol 45: 261

    Google Scholar 

  24. Curd JG, Velvington M, Burridge N, Stimler NP, Gerard C, Prograis LJ Jr. Cochrane C G, Müller-Eberhard H J (1982) Generation of bradykinin during incubation of hereditary angioedema plasma. Mol Immunol 19: 1365 (Abstract)

    Google Scholar 

  25. Cyong J-C, Witkin SS, Rieger B, Barbarese E, Good RA, Day NK (1982) Antibody independent complement activation by myelin via the classical complement pathway. J Exp Med 155: 587

    Google Scholar 

  26. Dodds AW, Sim PB, Porter RR, Kerr MA (1978) Activation of the first component of human complement (C1) by antibody-antigen aggregates. Biochem J 175: 383

    Google Scholar 

  27. Doekes G, Van Es LA, Daha MR (1982) Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates. Immunology 45: 705

    Google Scholar 

  28. Donaldson VH (1968) Mechanisms of activation of C1 esterase in hereditary angioneurotic edema plasma in vitro. The role of Hageman Factor, a clot promoting agent. J Exp Med 127: 411

    Google Scholar 

  29. Donaldson VH, Evans RR (1963) A biochemical abnormality in hereditary angioedema. Absence of serum inhibitor of C1-esterase. Am J Med 35: 37

    Google Scholar 

  30. Donaldson VH, Rosen FS, Bing DH (1977) Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma. Trans Assoc Am Physicians 90: 174

    Google Scholar 

  31. Emanuel EJ, Brampton AD, Burton DR, Dwek RA (1982) Formation of complement subcomponent C1q-immunoglobulin G complex. Biochem J 205: 361

    Google Scholar 

  32. Folkerd EJ, Gardner B, Hughes-Jones NC (1980) The relationship between the binding ability and the rate of activation of the complement component C1. Immunology 41: 179

    Google Scholar 

  33. Gabay Y, Perlmann J, Perlmann P, Sobel AT (1979) A rosette assay for the determination of C1q receptor bearing cells. Eur J Immunol 9: 797

    Google Scholar 

  34. Gelfand JA, Sherins RJ, Alling DW, Frank MM (1976) Treatment of hereditary angioedema with Danazol. Reversal of clinical and biochemical abnormalities. N Engl J Med 295: 1444

    Google Scholar 

  35. Gelfand JA, Boss GR, Lockard C, Conley CL, Reinhart R, Frank MM (1979) Acquired C1 esterase deficiency and angioedema: a review. Medicine 58: 321

    Google Scholar 

  36. Ghebrehiwet B, Hamburger M (1982) Purification and partial characterization of a C1q inhibitor from the membranes of human peripheral blood lymphocytes. J Immunol 129: 157

    Google Scholar 

  37. Ghebrehiwet B, Müller-Eberhard HJ (1978) Lysis of C1q-coated chicken erythrocytes by human lymphoblastoid cell lines. J Immunol 120: 27

    Google Scholar 

  38. Ghebrehiwet B, Silverberg M, Kaplan AP (1981) Activation of the classical pathway of complement by Hageman Factor fragment. J Exp Med 153: 665

    Google Scholar 

  39. Giclas PC (1982) Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function. J Immunol 129: 168

    Google Scholar 

  40. Giclas PC, Ginsberg MH, Cooper NR (1979) Immunoglobulin G independent activation of the classical complement pathway by monosodium urate crystals. J Clin Invest 63: 759

    Google Scholar 

  41. Giclas PC, Pinckard RN, Olson MS (1979) In vitro activation of complement by isolated human heart subcellular membranes. J Immunol 122: 146

    Google Scholar 

  42. Gigli I, Austen KF (1969) Fluid phase destruction of C2 by C1. II. Unmasking by C4i of C1 specificity for C2. J Exp Med 130: 833

    Google Scholar 

  43. Gilmour S, Randall JT, William KJ, Dwek RA, Tarbet J (1980) The conformation of subcomponent C1q of the first component of human complement. Nature 285: 512

    Google Scholar 

  44. Goers JW, Ziccardi RJ, Schumaker VN, Glovsky MM (1977) The mechanism of activation of the first component of human complement by a univalent hapten-IgG antibody complex. J Immunol 118: 2182.

    Google Scholar 

  45. Golan MD, Burger R, Loos M (1982) Conformational changes in C1q after binding to immune complexes: detection of neoantigens with monoclonal antibodies. J Immunol. 129: 445

    Google Scholar 

  46. Haines AL, Lepow IH (1964) Studies on human C1 esterase. I. purification and enzymatic properties. J Immunol 92: 456

    Google Scholar 

  47. Harpel PC, Cooper NR (1975) Studies on human plasma C1-inactivator-enzyme interactions. J Clin Invest 55: 593

    Google Scholar 

  48. Haupt H, Heimburger N, Kranz T, Schwick HG (1970) Ein beitrag zur isolierung und charakterisierung des C1-Inaktivators aus humanplasma. Eur J Biochem 17: 254

    Google Scholar 

  49. Hughes-Jones NC (1977) Functional affinity constants of the reaction between 125I-labelled C1q and C1q binders and their use in the measurement of plasma C1q concentrations. Immunology 32: 191

    Google Scholar 

  50. Hughes-Jones NC, Gorick BD (1982) The binding and activation of the C1r-C1s subunit of the first component of human complement. Mol Immunol 19: 1105

    Google Scholar 

  51. Hurt MM, Volanakis JE, Hester RB, Stroud RM, Bennett JC (1974) The structural basis for binding of complement by immunoglobulin M. J Exp Med 140: 1117

    Google Scholar 

  52. Isenman DE, Ellerson JR, Painter RH, Dorrington KJ (1977) Correlation between the exposure of aromatic chromophores at the surface of the Fc domains of immunoglobulin G and their ability to bind complement. Biochemistry 16: 233

    Google Scholar 

  53. Kaplan MH, Volanakis JE (1974) Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin, and sphingomyelin. J Immunol 112: 2135

    Google Scholar 

  54. Kasahara Y, Takahashi K, Nagasawa S, Koyama J (1982) Formation of a conformationally changed C1r, a subcomponent of the first component of human complement, as an intermediate of its autoactivation reaction. FEBS Lett 141: 128

    Google Scholar 

  55. Kilchherr E, Fuchs H, Tschopp J, Engel J (1982) Dissociation of C1 and concentration dependence of its activation kinetics. Mol Immunol 19: 683

    Google Scholar 

  56. Knobel H R, Heusser C, Rodrick M L, Isliker H (1974) Enzymatic digestion of the first component of human complement (C1q). J Immunol 112: 2094

    Google Scholar 

  57. Lachmann PJ, Rosen FS (1978) Genetic defects of complement in man. Springer Semin Immunopathol 1: 339

    Google Scholar 

  58. Laurell A-B, Martensson U, Sjoholm AG (1976) C1 subcomponent complexes in normal and pathological sera studied by crossed immunoelectrophoresis. Acta Pathol Microbiol Scand [C] 84: 455

    Google Scholar 

  59. Laurell A-B, Johnson U, Martensson U, Sioholm AG (1978) Formation of complexes composed of \(C\overline {1r}\), C\(C\overline {1s}\) and C1 inactivator in human serum on activation of C1. Acta Pathol Microbiol Scand [C] 86: 299

    Google Scholar 

  60. Lepow IH, Wurz L, Ratnoff OD, Pillemer L (1954) Studies on the mechanism of inactivation of human complement by plasmin and by antigen-antibody aggregates. I. The requirement for a factor resembling C1 and the role of Ca++. J Immunol 73: 146

    Google Scholar 

  61. Lepow IH, Ratnoff OD, Levy LR (1958) Studies on the activation of a proesterase associated with partially purified first component of human complement. J Exp Med 107: 451

    Google Scholar 

  62. Lepow IH, Naff GB, Todd EW, Pensky J, Hinz CF (1963) Chromatographic resolution of the first component of human complement into three activities. J Exp Med 117: 983

    Google Scholar 

  63. Lepow IH, Naff GB, Pensky J (1965) Mechanisms of activation of C1 and inhibition of C1 esterase. In: CIBA Foundation Symposium: Complement. Churchill, London, p 74

    Google Scholar 

  64. Liberti PA, Paul SM (1978) Gross conformation of C1q: a subcomponent of the first component of complement. Biochemistry 17: 1952

    Google Scholar 

  65. Liberti PA, Bausch PM, Schoenberg LM (1982) On the mechanism of C1q binding to antibody-I. Aggregation and/or distortion of IgG vs. combing site transmitted effects. Mol Immunol 19: 143

    Google Scholar 

  66. Lin T-Y, Fletcher DS (1978) Interaction of human C1q with insoluble immunoglobulin aggregates. Immunochemistry 15: 107

    Google Scholar 

  67. Lin T-Y, Fletcher DS (1980) Activation of a complex of C1r and C1s subcomponents of human complement C1 by the third subcomponent C1q. J Biol Chem 255: 7756

    Google Scholar 

  68. Linder E, Lehto V-P, Stenman S (1979) Activation of complement C cytoskeletal intermediate filaments. Nature 278: 176

    Google Scholar 

  69. Loos M (1982) The classical complement pathway: Mechanism of activation of the first component by antigen-antibody complexes. Prog Allergy 30: 135

    Google Scholar 

  70. Loos M (1982) The functions of endogenous C1q, a subcomponent of the first component of complement, as a receptor on the membrane of macrophages. Mol Immunol 19: 1229

    Google Scholar 

  71. Loos M, Bitter-Suermann D, Dierich M (1974) Interaction of the first (C1), the second (C2), and the fourth (C4) component of complement with different preparations of bacterial lipopolysaccharides and with lipid A. J Immunol 112: 935

    Google Scholar 

  72. Lucas TJ, Munoz H, Erickson BW (1981) Inhibition of C1-mediated immune hemolysis by monomeric and dimeric peptides from the second constant domain of human immunoglobulin G. J Immunol 127: 2555

    Google Scholar 

  73. McRae BJ, Lin T-Y, Powers JC (1981) Mapping the substrate binding site of human \(C\overline {1r}\) and C\(C\overline {1s}\) with peptide thioesters. J Biol Chem 256: 12362

    Google Scholar 

  74. Medicus RG, Chapuis RM (1981) The physiological mechanism of C1 activation Hoppe-Seyler's Z Physiol Chem 362: 17 (Abstract)

    Google Scholar 

  75. Menzel EJ, Smolen JS, Liotta L, Reid K B M (1981) Interaction of fibronectin with C1q and its collagen-like fragment (CLF). FEBS Lett 129: 188

    Google Scholar 

  76. Metzger H (1978) The effect of antigen on antibodies: Recent studies. Contemp Top Mol Immuno 7: 119

    Google Scholar 

  77. Minta J0 (1981) The role of sialic acid in the functional activity and the hepatic clearance of C1-Inh. J Immunol 126: 245

    Google Scholar 

  78. Minta JU, Aziz E (1981) Analysis of the reactive site peptide bond in C1-inhibitor by chemical modification of tyrosyl, lysyl and arginyl residues: The essential role of lysyl residues in the functional activity of C1-Inh. J Immunol 126: 250

    Google Scholar 

  79. Mizuochi T, Yonemasu K, Yamashita K, Kobata A (1978) The asparagine linked sugar chains of subcomponent C1q of the first component of human complement. J Biol Chem 253: 7404

    Google Scholar 

  80. Mullertz S, Clemmensen I (1976) The primary inhibitor of plasmin in human plasma. Biochem J 159: 545

    Google Scholar 

  81. Müller-Eberhard H J (1975) Complement. Annu Rev Biochem 44: 697

    Google Scholar 

  82. Naff GB, Ratnoff OP (1968) The enzymatic nature of C1r. Conversion of C1s to C1 esterase and digestion of amino acid esters by C1r. J Exp Med 128: 571

    Google Scholar 

  83. Osler W (1888) Hereditary angioneurotic edema. Am J Med Sci 95: 362

    Google Scholar 

  84. Pearlstein E, Sorvillo J, Gigli I (1982) The interaction of human plasma fibronectin with a subunit of the first component of complement C1q. J Immunol 128: 2036

    Google Scholar 

  85. Pensky J, Levy LR, Lepow IH (1961) Partial purification of a serum inhibitor of C1 esterase. J Biol Chem 236: 1674

    Google Scholar 

  86. Plaut AG, Cohen S, Tomasi TB Jr (1972) Immunoglobulin M: Fixation of human complement by the Fc fragment. Science 176: 55

    Google Scholar 

  87. Porter RP, Reid KBM (1978) The biochemistry of complement. Nature 275: 699

    Google Scholar 

  88. Prograis LJ Jr, Mathison DA, Cochrane CG, Müller-Eberhard HJ, Curd, JG (1983) The contact (Hageman factor) and complement systems in hereditary angioedema: alterations during attenuated androgen therapy. Am J Med to be published

  89. Reid KBM, Porter RR (1981) The proteolytic activation systems of complement. Annu Rev Biochem 50: 433

    Google Scholar 

  90. Reid KBM, Sim RB, Faiers AP (1977) Inhibition of the reconstitution of the hemolytic activity of the first component of human complement by a pepsin-derived fragment of subcomponent C1q. Biochem J 161: 239

    Google Scholar 

  91. Reid KBM, Gagnon J, Frampton J (1982) Completion of the amino acid sequences of the A and B chains subcomponent C1q of the first component of human complement. Biochem J 203: 559

    Google Scholar 

  92. Rosen FS, Alper CA, Pensky J, Klemperer MR, Donaldson VH (1971) Genetically delivered heterogenity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema. J Clin Invest 50: 2143

    Google Scholar 

  93. Ruddy S, Carpenter CB, Müller-Eberhard HJ, Austen KF (1967) In: Miescher PA, Grabar P (eds.) Immunopathology, Vth International Symposium. Mechanisms of inflammation induced by immune reactions. Grune and Stratton, New York, p 231

    Google Scholar 

  94. Sakai K, Stroud RM (1973) Purification, molecular properties and activation of C1 proesterase, C1s. J Immunol 110: 1010

    Google Scholar 

  95. Schultz DR, Arnold PI (1981) The first component of human complement: on the mechanism of activation by some carbohydrates. J Immunol 126: 1994

    Google Scholar 

  96. Schumaker VN, Calcott MA, Spiegelberg HL, Müller-Eberhard HJ (1976) Ultracentrifuge studies of the binding of IgG of different subclasses to the C1q subunit of the first component of complement. Biochemistry 15: 5175

    Google Scholar 

  97. Schumaker VN, Poon PH, Seegan GW, Smith C S (1981) Semi-flexible joint in the C1q subunit of the first component of human complement. J Mol Biol 148: 191

    Google Scholar 

  98. Shelton E, Yonemasu K, Stroud RM (1972) Ultrastructure of the human complement component, C1q. Proc Natl Acad Sci USA 69: 65

    Google Scholar 

  99. Siegel RC, Schumaker VN (1983) Measurement of the association constants of the complexes formed between intact C1q or pepsin-treated C1q stalks and the unactivated or activated C1r2s2 tetramers. Mol Immunol 20: 53

    Google Scholar 

  100. Siegel RC, Schumaker VN, Poon PK (1981) Stoichiometry and sedimentation properties of the complex formed between C1q and C1r2s2 subcomponent of the first component of complement. J Immunol 127: 2447

    Google Scholar 

  101. Silvestri L, Baker JR, Roden L, Stroud RM (1981) The C1q inhibitor in serum is a chondroitin 4-sulfate proteoglycan. J Biol Chem 256: 7383

    Google Scholar 

  102. Sim PB, Porter RB, Reid KBM, Gigli I (1977) The structure and enzymatic activities of the C1r and C1s subcomponents of C1, the first component of human serum complement. Biochem J 163: 219

    Google Scholar 

  103. Sim RB, Arlaud GJ, Colomb MG (1979) C1-Inhibitor dependent dissociation of human complement C\(1\) bound to immune complexes. Biochem J 179: 449

    Google Scholar 

  104. Sim RB, Reboul A, Arlaud GJ, Villiers CL, Colomb, MG (1979) Interaction of 125I-labelled complement subcomponents \(C\overline {1r}\) and \(C\overline {1s}\) with protease inhibitors in plasma. FEBS Lett 97: 111

    Google Scholar 

  105. Sobel AT, Bokisch VA (1975) Receptors for C4b and C1q on human peripheral lymphocytes and lymphoblastoid cells. In: Seligmann M, Preud' homme TL, Kourilsky FM (eds.) Membrane receptors of lymphocytes. North Holland Publishing Co, Amsterdam, p 151

    Google Scholar 

  106. Storrs SB, Kolb WP, Pinckard RN, Olson MS (1981) Characterization of the binding of purified human C1q to heart mitochrondrial membranes. J Biol. Chem 256: 10924

    Google Scholar 

  107. Strang CJ, Siegel RC, Phillips ML, Poon PH, Schumaker VN (1982) Ultrastructure of the first component of human complement: electron microscopy of the crosslinked complex. Proc Natl Acad Sci USA 79: 586

    Google Scholar 

  108. Strunk R, Colten HR (1974) The first component of human complement (C1): kinetics of reaction with its natural substrate. J Immunol 112: 905

    Google Scholar 

  109. Tenner AJ, Cooper NR (1980) Analysis of receptor-mediated C1q binding to human peripheral blood mononuclear cells. J Immunol 125: 1658

    Google Scholar 

  110. Tenner AJ, Cooper NR (1981) Identification of types of cells in human peripheral blood that bind C1q. J Immunol 126: 1174

    Google Scholar 

  111. Tenner AJ, Cooper NR (1982) Stimulation of a human polymorphonuclear leukocyte oxidative response by the C1q subunit of the first complement component. J Immunol 128: 2547

    Google Scholar 

  112. Thielens NM, Villiers M-B, Reboul A, Villiers CL, Colomb MG (1982) Human complement subcomponent C2: purification and proteolytic cleavage in fluid phase by C1s, C1r2-C1s2 and C1. FEBS Lett 141: 19

    Google Scholar 

  113. Tschopp J (1982) Kinetics of activation of the first component of complement (C1) by IgG oligomers. Mol Immunol 19: 651

    Google Scholar 

  114. Tschopp J, Schulthess T, Engel J, Jaton J-C (1980) Antigen-idependent activation of the first component of complement C1 by chemically crosslinked rabbit IgG-oligmers. FEBS Lett 112: 152

    Google Scholar 

  115. Tschopp J, Villiger W, Fuchs H, Kilchherr E, Engel J (1980) Assembly of subcomponents C1r and C1s of first component of complement: electron microscopic and ultracentrifugal studies. Proc Natl Acad Sci USA 77: 7014

    Google Scholar 

  116. Vanguri P, Koski CL, Silverman B, Shin ML (1982) Complement activation by isolated myelin: Activation of the classical pathway in the absence of myelin specific antibodies. Proc Natl Acad Sci USA 79: 3290

    Google Scholar 

  117. Villiers CL, Arlaud GJ, Painter RH, Colomb MG (1980) Calcium binding properties of the C1 subcomponents C1q, C1r and C1s. FEBS Lett 117: 289

    Google Scholar 

  118. Villiers CL, Duplaa A-M, Arlaud GJ, Colomb MG (1982) Fluid phase activation of proenzymic C1r purified by affinity chromatography. Biochim Biophys Acta 700: 118

    Google Scholar 

  119. Villiers CL, Chesne S, Lacroix MB, Arlaud GJ, Colomb MG (1982) Structural features of the first component of human complement, C1, as revealed by surface iodination. Biochem J 203: 185

    Google Scholar 

  120. Wautier JL, Souchon H, Reid KBM, Peltier AP, Caen JP (1977) Studies on the mode of reaction of the first component of complement with platelets: interaction between collagen-like portion of C1q and platelets. Immunochemistry 14: 763

    Google Scholar 

  121. Yan D, Gu X, Wang D, Yang S (1981) Studies on immunopathogenesis in epidemic hemorrhagic fever: sequential observations on activation of the first complement component in sera from patients with epidemic hemorrhagic fever. J Immunol 127: 1064

    Google Scholar 

  122. Ziccardi RJ (1980) Specific C1 dissociation immunoassay as an indicator for classical pathway activation of complement and C1-Inactivator function. Lab Res Methods Biol Med 4: 433

    Google Scholar 

  123. Ziccardi RJ (1981) Activation of the early components of the classical complement pathway under physiologic conditions. J Immunol 126: 1769

    Google Scholar 

  124. Ziccardi RJ (1982) Initiation of the classical complement pathway: control of activator mediated and spontaneous C1 activation. Mol Immunol 19: 1413 (Abstract)

    Google Scholar 

  125. Ziccardi RJ (1982) Spontaneous activation of the first component of human complement (C1) by an intramolecular autocatalytic mechanism. J Immunol 128: 2500

    Google Scholar 

  126. Ziccardi RJ (1982) A new role for C1-Inhibitor in homeostasis: Control of activation of the first component of human complement. J Immunol 128: 2505

    Google Scholar 

  127. Ziccardi RJ (1983) Nature of the metal ion requirement for assembly and function of the first component of human complement (C1). J Biol Chem 258: 6187

    Google Scholar 

  128. Ziccardi RJ, Cooper NR (1976) Physicochemical and functional characterization of the C1r subunit of the first complement component. J Immunol 116:496

    Google Scholar 

  129. Ziccardi RJ, Cooper NR (1976) Activation of C1r by proteolytic cleavage. J. Immunol 116: 504

    Google Scholar 

  130. Ziccardi RJ, Cooper NR (1977) The subunit composition and sedimentation properties of human C1. J Immunol 118: 2047

    Google Scholar 

  131. Ziccardi RJ, Cooper NR (1978) Demonstration and quantitation of activation of the first component of complement in human serum. J Exp Med 147: 385

    Google Scholar 

  132. Ziccardi R J, Cooper N R (1978) Direct demonstration and quantitation of the first complement component in human serum. Science 199: 1080

    Google Scholar 

  133. Ziccardi RJ, Cooper NR (1978) Modulation of the antigenicity of C1r and C1s by C1 inactivator. J Immunol 121: 2148

    Google Scholar 

  134. Ziccardi RJ, Cooper NR (1979) Active disassembly of the first complement component, C1, by C1-Inactivator. J Immunol 123: 788

    Google Scholar 

  135. Ziccardi RJ, Cooper NR (1980) Development of an immunochemical test to assess C1-Inactivator function in human serum and its use for the diagnosis of hereditary angioedema. Clin Immunol Immunopathol 15: 465

    Google Scholar 

  136. Ziccardi RJ, Tschopp J (1982) The dissociation properties of native C1. Biochem Biophys Res Commun 107: 618

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Immunology, Research Institute of Schripps Clinic, 92037, La Jolla, California, USA

    Robert J. Ziccardi

Authors
  1. Robert J. Ziccardi
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This is publication number 2981 IMM from the Research Institute of Scripps Clinic. This work was supported by United States Public Health Service Grant AI 14502

Dr. Ziccardi is the recipient of Established Investigatorship 79–139 from the American Heart Association

Abbreviations used in this paper: C1 or C1qr 2 s 2 first component of complement; C \(1\), C \(1\) r 2 s 2 , C \(1\) r, and C \(1\) s activated forms of respective proteins; C1-In C1-inhibitor; C2 second component of complement; C4 fourth component of complement; EDTA ethylenediaminetetraacetic acid; HAE hereditary angioedema; IC immune complex; K assoc association constant; M moles/liter; mol. wt molecular weight; NHS normal human serum; SDS PAGE polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ziccardi, R.J. The first component of human complement (C1): Activation and control. Springer Semin Immunopathol 6, 213–230 (1983). https://doi.org/10.1007/BF00205874

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00205874

Keywords

Search

Navigation